{"date":"2025-11-26","count":13,"source":"公開資訊觀測站（MOPS）","attribution":"引用請註明：Drugnews 事實帳本（https://drugnews.com.tw/filings/）與公開資訊觀測站原始公告","records":[{"id":"tw-6576-2025-11-26-1837-vqkii","company_id":"6576","company":"逸達","market":"上櫃","industry":"生技醫療","date":"2025-11-26","time":"18:37:59","subject":"公告本公司註銷限制員工權利新股減資變更登記完成","clause":"第36款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：逸達（6576），2025-11-26 18:37，「公告本公司註銷限制員工權利新股減資變更登記完成」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6879-2025-11-26-1836-1nk95l9","company_id":"6879","company":"大江基因","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"18:36:57","subject":"公告本公司「人類臍帶間質幹細胞細胞外囊泡」經美國個人護理產品協會(PCPC) 審查通過，取得國際INCI新原料認證(INCIname)","clause":"第44款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：大江基因（6879），2025-11-26 18:36，「公告本公司「人類臍帶間質幹細胞細胞外囊泡」經美國個人護理產品協會(PCPC) 審查通過，取得國際INCI新原料認證(IN」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4170-2025-11-26-1759-11al93r","company_id":"4170","company":"鑫品生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"17:59:56","subject":"本公司「人類臍帶間質幹細胞外泌體 (Human UmbilicalMesenchymal Stem Cell Exosomes)」經美國個人護理產品協會(PCPC)審查通過，獲國際INCI新原料認證(INCI name)","clause":"第44款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：鑫品生醫（4170），2025-11-26 17:59，「本公司「人類臍帶間質幹細胞外泌體 (Human UmbilicalMesenchymal Stem Cell Exoso」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-4746-2025-11-26-1736-190fsk7","company_id":"4746","company":"台耀","market":"上市","industry":"生技醫療","date":"2025-11-26","time":"17:36:44","subject":"本公司受邀參加永豐金證券舉辦之法人說明會","clause":"第12款","fact_date":"2025-11-28","cite_as":"公開資訊觀測站重大訊息：台耀（4746），2025-11-26 17:36，「本公司受邀參加永豐金證券舉辦之法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-11-26-1644-5rh607","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:44:08","subject":"公告本公司董事會決議解除經理人競業禁止之限制","clause":"第22款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-11-26 16:44，「公告本公司董事會決議解除經理人競業禁止之限制」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-11-26-1642-wr0tu2","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:42:44","subject":"公告本公司總經理異動","clause":"第6款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-11-26 16:42，「公告本公司總經理異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-11-26-1639-1g6i233","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:39:44","subject":"公告本公司董事長異動","clause":"第6款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-11-26 16:39，「公告本公司董事長異動」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6815-2025-11-26-1638-chywoa","company_id":"6815","company":"晶鑽生醫","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:38:47","subject":"公告本公司董事會決議以私募現金增資發行普通股案","clause":"第9款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：晶鑽生醫（6815），2025-11-26 16:38，「公告本公司董事會決議以私募現金增資發行普通股案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6467-2025-11-26-1622-1fe9r1v","company_id":"6467","company":"泰合","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:22:50","subject":"本公司TAH3311抗血栓口溶膜505(b)(2)新劑型新藥藥證申請接獲美國食品藥物管理局(FDA)資料不完全通知","clause":"第44款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：泰合（6467），2025-11-26 16:22，「本公司TAH3311抗血栓口溶膜505(b)(2)新劑型新藥藥證申請接獲美國食品藥物管理局(FDA)資料不完全通知」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2025-11-26-1621-10znpaf","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:21:01","subject":"公告本公司董事會通過發言人及代理發言人任命案","clause":"第11款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：科明（7881），2025-11-26 16:21，「公告本公司董事會通過發言人及代理發言人任命案」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-7881-2025-11-26-1618-fo0d32","company_id":"7881","company":"科明","market":"興櫃","industry":"生技醫療","date":"2025-11-26","time":"16:18:58","subject":"本公司董事會決議召開115年第一次股東臨時會","clause":"第32款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：科明（7881），2025-11-26 16:18，「本公司董事會決議召開115年第一次股東臨時會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6657-2025-11-26-1550-1kn4001","company_id":"6657","company":"華安","market":"上市","industry":"生技醫療","date":"2025-11-26","time":"15:50:01","subject":"本公司接獲CRO機構通知，本公司研發中新藥ENERGI-F703EB遺傳性表皮分解性水皰症乳膏，向美國食品藥物管理局(FDA)申請執行人體二期臨床試驗可開始執行人體二期臨床試驗。","clause":"第10款","fact_date":"2025-11-26","cite_as":"公開資訊觀測站重大訊息：華安（6657），2025-11-26 15:50，「本公司接獲CRO機構通知，本公司研發中新藥ENERGI-F703EB遺傳性表皮分解性水皰症乳膏，向美國食品藥物管理局(F」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"},{"id":"tw-6929-2025-11-26-1546-16sohr8","company_id":"6929","company":"佑全","market":"上櫃","industry":"生技醫療","date":"2025-11-26","time":"15:46:14","subject":"本公司受邀參加元大證券舉辦之線上法人說明會","clause":"第12款","fact_date":"2025-11-27","cite_as":"公開資訊觀測站重大訊息：佑全（6929），2025-11-26 15:46，「本公司受邀參加元大證券舉辦之線上法人說明會」。經 Drugnews 事實帳本收錄：https://drugnews.com.tw/mcp/filings.json"}]}